Downregulation of Keap1 by miR-200a also effectively enhanced Nrf2 function and protected against albuminuria, oxidative stress, and fibrosis in streptozotocin-induced diabetic nephropathy [111, 117, 118]. This evidence concerns the gene NFE2L2 and diabetic kidney disease.